Regeneron, bluebird bio partner to discover, develop & commercialize new cell therapies for cancer

Regeneron Pharmaceuticals, Inc.,a leading biotechnology company, and bluebird bio, Inc. announced a collaboration to apply their respective technology platforms to the discovery, development and

More From BioPortfolio on "Regeneron, bluebird bio partner to discover, develop & commercialize new cell therapies for cancer"